Standex director Charles H. Cannon plans $235K sale
The 908 shares are listed as compensation-related restricted stock vesting dated October 24, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Standex International Corp. (SXI) director Charles H. Cannon reported an intended sale of 908 common shares through Fidelity Brokerage Services LLC, with an approximate sale date of November 4, 2026, on the NYSE. The listed aggregate market value is $235,199.24. The shares were acquired from the issuer through restricted stock vesting on October 24, 2026, as compensation.
Key Figures
Key Terms
Restricted Stock Vesting technical
Rule 144 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.